FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Chiesi Zyflo Cr Recall

ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only, Distr…

Chiesi USA, Inc. · Cary, NC

Risk level
Class II
Reported by FDA
Jun 19, 2019
Recall ID
D-1341-2019
Check your lot numberHow we source this data

Summary

Chiesi recalled Zyflo Cr starting May 31, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1341-2019 on Jun 19, 2019. Reason: Failed Dissolution Specifications: Out of specification result for dissolution. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Out of specification result for dissolution.

Product description

ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only, Distributed by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-902-12.

Lot numbers, UPCs & expiration codes

Lots: 3171855, Exp. 12/19

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1341-2019
Classification
Class II
Status
Terminated
Recall initiated
May 31, 2019
FDA report date
Jun 19, 2019
Quantity
2118 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Chiesi USA, Inc.

Original FDA data

Every field from FDA enforcement report D-1341-2019, exactly as published.

Show all FDA fields
City
Cary
State
NC
Status
Terminated
Country
United States
Event ID
82993
Address
175 Regency Woods Place, Ste. 600
Code information
Lots: 3171855, Exp. 12/19
Postal code
27518-8128
Report date
Jun 19, 2019
Product type
Drugs
Recall number
D-1341-2019
Classification
Class II
Recalling firm
Chiesi USA, Inc.
Product quantity
2118 bottles
Termination date
Mar 8, 2021
Reason for recall
Failed Dissolution Specifications: Out of specification result for dissolution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only, Distributed by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-902-12.
Distribution pattern
Nationwide in the USA.
Recall initiation date
May 31, 2019
Initial firm notification
Letter
Center classification date
Jun 13, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1341-2019, published Jun 19, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls